comparemela.com

Latest Breaking News On - வைரஸ் நோய் கட்டுப்பாடு - Page 1 : comparemela.com

NIH Gave Millions to Chinese Entities to Study Infectious Diseases

NIH Gave Millions to Chinese Entities to Study Infectious Diseases
dailysignal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailysignal.com Daily Mail and Mail on Sunday newspapers.

Explained: What is Monkey B Virus that has claimed its first victim in China

Explained: What is Monkey B Virus that has claimed its first victim in China The Monkey B Virus has been reported in China, where a veterinary surgeon died after he contacted it while dissecting two monkeys. advertisement UPDATED: July 19, 2021 16:33 IST The Monkey BV is caused by macaques, a genus of Old World monkeys. (Representative Photo/Getty) As the world grapples with the devastating Covid-19 pandemic, a new viral infection has been reported in China. The Monkey B Virus (BV) claimed its first victim in the country after a veterinary surgeon contacted the virus while dissecting two animals. The case, first reported in March of this year, was revealed in the Chinese Center for Disease Control and Prevention (China CDC) briefing last week. The surgeon died in May after visiting several hospitals. According to reports, analysis of the cerebrospinal fluid from the patient indicated alphaherpesvirus infection.

Columbia Professor Who Thanked Fauci for Dismissing Lab Leak Theory Has History of Collaboration With China

Columbia Professor Who Thanked Fauci for Dismissing Lab Leak Theory Has History of Collaboration With China
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development

Author of the article: GlobeNewswire Publishing date: Apr 27, 2021  •  51 minutes ago  •  4 minute read  •  Article content Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products Administration (NMPA) MIRAMAR, Fla., April 27, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that in connection with its partnership with the National Institute for Viral Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing Youfeng International Consulting Co., Ltd and Beijing Guoxin Haixiang Equity Investment Partnership, the company has received a $2 million development payment from Beijing Youfeng Biological Technology, Ltd (Youfeng-BI). In exchange for this payment, Generex will provide

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.